NAV1.4 Voltage-Gated Sodium Channel
"NAV1.4 Voltage-Gated Sodium Channel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A voltage-gated sodium channel subtype that mediates the sodium ion PERMEABILITY of SKELETAL MYOCYTES. Defects in the SCN4A gene, which codes for the alpha subunit of this sodium channel, are associated with several MYOTONIC DISORDERS.
Descriptor ID |
D062553
|
MeSH Number(s) |
D12.776.157.530.400.875.750.400 D12.776.210.500.675 D12.776.543.550.450.875.750.400 D12.776.543.585.400.875.750.400
|
Concept/Terms |
NAV1.4 Voltage-Gated Sodium Channel- NAV1.4 Voltage-Gated Sodium Channel
- NAV1.4 Voltage Gated Sodium Channel
- Voltage-Gated Sodium Channel Type 4
- Voltage Gated Sodium Channel Type 4
- Type 4 Voltage-Gated Sodium Channel
- Type 4 Voltage Gated Sodium Channel
Voltage-Gated Sodium Channel Type 4 Subunit alpha- Voltage-Gated Sodium Channel Type 4 Subunit alpha
- Voltage Gated Sodium Channel Type 4 Subunit alpha
- SCN4A Sodium Channel alpha Subunit
- Sodium Channel, Voltage-Gated, Type IV, alpha 1 Subunit
- NAV1.4 alpha Subunit
- Subunit, NAV1.4 alpha
- alpha Subunit, NAV1.4
|
Below are MeSH descriptors whose meaning is more general than "NAV1.4 Voltage-Gated Sodium Channel".
Below are MeSH descriptors whose meaning is more specific than "NAV1.4 Voltage-Gated Sodium Channel".
This graph shows the total number of publications written about "NAV1.4 Voltage-Gated Sodium Channel" by people in this website by year, and whether "NAV1.4 Voltage-Gated Sodium Channel" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "NAV1.4 Voltage-Gated Sodium Channel" by people in Profiles.
-
Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord. 2010 Mar; 20(3):166-73.